Insiders
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Mikael Dolsten](https://cdn.zonebourse.com/static/resize/768/768/https://zonebourse.com/images/barons/mikael_dolsten_biographie.jpg)
Mikael Dolsten holds the position of Chief Scientific Officer & Research President at Pfizer Inc. Dr. Dolsten is also on the board of New York Academy of Sciences, Karyopharm Therapeutics, Inc. and PhRMA Foundation and Member of Royal Swedish Academy of Engineering Sciences and Member of Government-University-Industry Research Roundtable. In the past he occupied the position of Principal at OrbiMed Advisors LLC and Partner at OrbiMed Advisors Private Equity (a subsidiary of OrbiMed Advisors LLC), President for Wyeth Research, EVP, Global Head-Pharma Research & Discovery at Boehringer Ingelheim Pharmaceuticals, Inc., Senior Vice President for Wyeth Corp. and Member-Benefits, Law & Regulatory Committee at Wyeth Pharmaceuticals LLC. Dr. Dolsten received a doctorate from the University of Lund.
View full profileLatest news about Mikael Dolsten
- Stock Market
- Insiders
- Mikael Dolsten
- Pfizer Begins External Search for Chief Scientific Officer